Compounds useful for treating gastrointestinal tract disorders
US-2025263401-A1 · Aug 21, 2025 · US
This page is not indexed by search engines while we improve data quality.
DOTSENKO Irina patents
DOTSENKO Irina is listed as an inventor on 18 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | DOTSENKO Irina |
| Total patents | 18 |
| First publication | Nov 30, 2017 |
| Latest publication | Aug 21, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Compounds useful for treating gastrointestinal tract disorders
US-12281103-B2 · Apr 22, 2025 · US
Compounds useful for treating gastrointestinal tract disorders
US-2024317719-A1 · Sep 26, 2024 · US
Compounds useful for treating gastrointestinal tract disorders
US-2022306610-A1 · Sep 29, 2022 · US
Compounds useful for treating gastrointestinal tract disorders
US-11242337-B2 · Feb 8, 2022 · US
Inhibitors of NHE-mediated antiport
US-11147884-B2 · Oct 19, 2021 · US
Pegylated carfilzomib compounds
US-11077198-B2 · Aug 3, 2021 · US
Pegylated Carfilzomib Compounds
US-2020376131-A1 · Dec 3, 2020 · US
Pegylated carfilzomib compounds
US-10675353-B2 · Jun 9, 2020 · US
Pegylated carfilzomib compounds
US-2020069808-A1 · Mar 5, 2020 · US
Recent patents
Latest publications not already listed above.
Pegylated carfilzomib compounds
US-10517954-B2 · Dec 31, 2019 · US
Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
US-2019374533-A1 · Dec 12, 2019 · US
Inhibitors of nhe-mediated antiport
US-2019374649-A1 · Dec 12, 2019 · US
Compounds useful for treating gastrointestinal tract disorders
US-2019359599-A1 · Nov 28, 2019 · US
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
US-10376481-B2 · Aug 13, 2019 · US
Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
US-2017368004-A1 · Dec 28, 2017 · US
Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
US-2017340623-A1 · Nov 30, 2017 · US
Pegylated carfilzomib compounds
US-2017340746-A1 · Nov 30, 2017 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Ardelyx Inc | 12 |
| Amgen Inc | 6 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K31/18 | 10 |
| A61P3/12 | 8 |
| A61K47/55 | 8 |
| C07D401/12 | 8 |
| C07D401/14 | 8 |